larg
number
accident
viru
infect
occur
medic
nonmed
worker
expos
infecti
individu
materi
evalu
whether
postmortem
blood
bloodstain
contain
hepat
b
viru
hbv
infecti
hbvinfect
blood
bloodstain
store
day
room
temperatur
subsequ
screen
hepat
b
surfac
antigen
hbsag
hbv
dna
addit
hbvposit
postmortem
blood
ad
cell
line
product
hbv
virion
examin
period
day
hbsag
hbv
dna
detect
sampl
store
day
room
temperatur
hbvposit
postmortem
blood
success
infect
cell
line
progeni
virus
produc
day
thu
crucial
due
care
taken
handl
live
materi
infect
hbv
well
harm
virus
also
blood
bodi
fluid
cadav
medic
wast
scene
largescal
disast
terrorist
attack
consider
number
casualti
mani
nonmed
specialist
includ
polic
offic
firefight
must
work
togeth
medic
team
save
survivor
investig
caus
incid
ebola
viru
outbreak
medic
team
assist
patient
also
mani
member
public
secondarili
infect
ebola
viru
custom
touch
deceas
funer
februari
peopl
includ
forens
doctor
univers
tokyo
polic
offic
infect
tuberculosi
transfer
autopsi
infect
corps
corps
unknown
medic
histori
often
examin
field
forens
medicin
outbreak
ebola
viru
middl
east
respiratori
syndrom
coronaviru
japanes
govern
enact
number
measur
prevent
transmiss
secondari
infect
travel
howev
measur
focus
live
individu
infect
corps
consid
unfortun
difficult
identifi
infect
cadav
live
individu
check
travel
record
symptom
therefor
import
analyz
risk
infect
infect
corps
excess
prevent
measur
deal
potenti
infect
corps
adequ
costbenefit
point
view
unnecessari
steril
may
result
environment
pollut
also
unknown
long
viru
remain
infecti
corps
bloodstain
best
knowledg
report
clearli
examin
issu
previou
studi
repres
harm
viru
examin
hepat
c
viru
hcv
detect
blood
bloodstain
store
room
temperatur
day
hcvrna
found
detect
blood
bloodstain
day
antihcv
antibodi
hcvab
also
detect
day
hcvab
screen
also
use
evalu
postmortem
blood
bloodstain
sampl
howev
even
genom
viru
detect
still
certain
whether
viru
capsid
also
intact
addit
viru
capsid
intact
still
unclear
whether
viru
still
infecti
hcv
difficult
cultur
cell
vitro
cultur
hcv
isol
directli
patient
sera
yet
unattain
hepat
b
viru
hbv
partial
doublestrand
envelop
dna
viru
classifi
within
hepadnavirida
well
member
hepat
viru
group
hcv
despit
avail
vaccin
hbv
infect
still
global
health
problem
sinc
million
peopl
estim
chronic
infect
hbv
die
annual
cancer
liver
dysfunct
associ
hbv
infect
hbv
grown
easili
cell
cultur
therefor
studi
select
hbv
repres
harm
viru
analysi
store
hbvinfect
blood
bloodstain
day
room
temperatur
examin
hbv
dna
hepat
b
surfac
antigen
hbsag
could
detect
addit
hbvinfect
postmortem
blood
ad
cell
line
examin
hbvinfect
cell
line
could
produc
progeni
viru
hbvinfect
blood
sampl
obtain
inform
consent
patient
men
women
mean
age
year
rang
year
univers
hospit
kyoto
prefectur
univers
medicin
aiseikai
yamashina
hospit
serolog
analysi
clinic
diagnosi
tabl
prior
experi
hbv
dna
titer
clinic
sampl
determin
use
coba
taqman
hbv
dna
assay
roch
molecular
system
pleasanton
ca
titer
rang
log
iuml
averag
log
iuml
limit
detect
log
iuml
sampl
store
use
bloodstain
sampl
prepar
soak
cotton
bud
ml
hbvinfect
whole
blood
sampl
n
min
dri
room
temperatur
day
hbvinfect
whole
blood
sampl
n
place
seal
test
tube
kept
room
temperatur
day
prepar
blood
bloodstain
sampl
analyz
day
prepar
hbsag
bloodstain
whole
blood
sampl
detect
use
immunochromatographi
ortho
quick
chaser
hbsag
kit
ortho
clinic
diagnost
tokyo
japan
test
bloodstain
sampl
soak
salin
extract
solut
analyz
use
immunochromatographi
limit
detect
ngml
dna
extract
dilut
whole
blood
solut
extract
bloodstain
materi
qiaamp
dna
mini
kit
qiagen
hilden
germani
extract
dna
elut
elut
buffer
use
genom
amplif
hbv
gene
use
pcr
amplitaq
gold
dna
polymeras
appli
biosystem
llc
foster
citi
ca
usa
aliquot
contain
gold
buffer
deoxynucleosid
triphosph
mm
mgcl
primer
sens
primer
tag
act
cgt
ggt
gga
ctt
ctc
antisens
primer
cca
aac
agt
ggg
gga
use
previous
dna
polymeras
initi
activ
min
pcr
pcr
amplif
perform
cycl
follow
final
step
min
amplif
carri
thermal
cycler
astec
fukuoka
japan
pcr
product
mix
load
buffer
orang
g
subject
electrophoresi
agaros
gel
v
min
electrophores
agaros
gel
stain
ethidium
bromid
august
bodi
found
float
sea
fisherman
coast
rescu
helicopt
arriv
scene
soon
emerg
call
howev
victim
found
cardiopulmonari
arrest
pronounc
dead
pm
unidentifi
caus
death
unknown
therefor
bodi
sent
autopsi
next
day
caus
death
determin
drown
subsequ
polic
investig
reveal
male
textil
manufactur
live
neighbor
citi
previou
day
gone
fish
around
medic
histori
never
found
sampl
whole
blood
taken
autopsi
case
immedi
separ
hbv
copi
number
measur
log
copiesml
sampl
compon
store
use
human
hepatocyt
carcinomaderiv
cell
obtain
riken
bioresourc
center
nation
bioresourc
project
ministri
educ
cultur
sport
scienc
technolog
mext
japan
experi
start
week
autopsi
cell
line
cellswel
plate
tissu
cultur
dish
blood
sampl
contain
log
copiesml
hbv
iuml
dilut
ml
dilut
whole
blood
sampl
ad
individu
dish
contain
cell
line
incub
addit
ml
dmem
fetal
bovin
serum
streptomycin
h
dish
wash
fresh
medium
incub
addit
h
subsequ
medium
chang
dish
sampl
spent
medium
sent
hbv
analysi
day
th
th
day
medium
chang
everi
h
dish
spent
medium
sampl
sent
hbv
analysi
hbv
analysi
perform
hbsag
detect
pcr
amplif
hbv
genom
use
aforement
method
hbvinfect
blood
sampl
obtain
inform
consent
studi
approv
institut
review
board
kyoto
prefectur
univers
medicin
hbvdna
hbsag
detect
blood
bloodstain
sampl
store
room
temperatur
day
viral
load
log
iuml
detect
tabl
sampl
studi
therefor
posit
hbsag
hbvdna
postmortem
case
hbsag
hbv
dna
detect
cell
line
hbv
copi
copiesml
detect
day
day
cell
death
occur
cultur
discontinu
hbsag
hbvdna
detect
dilut
sampl
hbvposit
whole
blood
tabl
studi
sampl
posit
hbvdna
hbsag
may
indic
viru
capsid
sustain
consider
period
time
blood
bloodstain
addit
fact
hbv
postmortem
blood
infect
cell
line
indic
need
care
handl
materi
come
contact
corps
blood
bodi
fluid
almost
hbv
infect
occur
perinat
period
within
month
birth
hbv
vaccin
first
went
sale
mani
countri
hbv
vaccin
newborn
babi
medic
worker
start
therefor
hbvposit
rate
blood
donor
low
approxim
nowaday
infect
rate
hbv
lower
hcv
howev
despit
vaccin
peopl
whose
antihb
titer
neg
less
iuml
although
said
immunolog
memori
persist
case
vaccin
issu
merit
consider
unit
state
medic
worker
posit
antihbc
higher
rate
blood
donor
indic
medic
worker
high
risk
infect
approxim
hbvrelat
transmiss
healthcar
worker
via
percutan
injuri
scalpel
needl
remain
mode
transmiss
worker
via
mucosalcutan
exposur
individu
posit
hbsag
hbeag
risk
hepat
even
highrisk
work
environ
medic
worker
exist
knowledg
infecti
diseas
appropri
use
guard
glove
mask
howev
higher
risk
infect
becom
antihbcposit
nonmed
worker
lack
medic
expertis
attend
disast
risk
hbv
infect
reduc
univers
vaccin
sever
countri
howev
infect
risk
medic
field
also
gener
popul
remain
high
therefor
advis
extend
univers
vaccin
rest
world
studi
although
singl
case
hbv
postmortem
blood
success
infect
cell
line
tabl
cell
human
hepatoblastoma
cell
line
deriv
male
welldifferenti
carcinoma
cell
differ
morpholog
primari
hepatocyt
recent
sodium
taurochol
cotransport
polypeptid
ntcp
identifi
receptor
hbv
howev
express
cell
howev
report
describ
bind
entri
hbv
use
normal
cell
furthermor
although
virion
product
observ
studi
follow
transfect
hbv
dna
relat
studi
therefor
possibl
mechan
viral
entri
cell
hepatocyt
clearli
elucid
case
studi
use
normal
cell
observ
infect
hbv
even
though
much
easier
infect
cell
hbv
follow
ntcp
express
even
challeng
condit
without
ntcp
express
hbsag
hbv
dna
detect
cultur
cell
find
conclud
directli
hbv
postmortem
materi
remain
infecti
human
instanc
may
due
residu
hbv
cultur
dish
howev
least
say
possibl
infect
singl
case
signific
ill
past
medic
histori
addit
present
signific
gross
patholog
within
liver
tissu
figur
interestingli
even
inact
case
postmortem
blood
still
potenti
infecti
therefor
increas
prepared
awar
concern
possibl
infect
postmortem
materi
fund
work
support
grantinaid
scientif
research
c
japan
societi
promot
scienc
author
declar
conflict
interest
ethic
approv
procedur
perform
studi
involv
human
particip
accord
ethic
standard
institut
research
committe
helsinki
declar
later
amend
compar
ethic
standard
studi
approv
institut
review
board
kyoto
prefectur
univers
medicin
inform
consent
inform
consent
obtain
individu
particip
includ
studi
liver
tissu
clinic
postmortem
case
centrilobular
necrosi
singl
arrow
slight
fibrosi
glisson
sheath
seen
doubl
arrow
howev
activ
infiltr
inflammatori
cell
seen
